| Active Ingredient | Spironolactone |
| Brand | Silectone |
| Country of origin | India |
| Form | Oral tablets |
Silectone 25 tablet is a potassium-sparing diuretic that contains Spironolactone. It helps remove excess fluid from the body while retaining potassium and is primarily used to manage heart failure and high blood pressure.
Clinical Uses
Silectone-25 tablet is used to manage high blood pressure, fluid retention (oedema), and heart failure. It is also prescribed for hyperaldosteronism, a condition caused by excess aldosterone production. In women, it may be used under medical supervision to manage-
- Acne
- Excessive hair growth (hirsutism)
- Symptoms associated with polycystic ovary syndrome (PCOS)
It works by blocking the effects of androgens.
How It Works
Silectone 25mg tablet is a potassium-sparing diuretic that helps lower blood pressure and reduce swelling by removing excess water and sodium from the body while retaining potassium. This helps manage fluid retention and reduces the workload on the heart.
Side Effects
Common side effects of Silectone 25 tablet include nausea, vomiting, dizziness, and breast swelling or tenderness in both men and women. If these side effects persist or worsen, consult your doctor.
Precautions & Warnings
- Use this medicine only as prescribed by your doctor.
- Monitor potassium levels regularly, as spironolactone may cause high potassium levels in the blood (hyperkalaemia).
- Inform your doctor if you have kidney or liver problems before starting treatment.
- Avoid potassium supplements and potassium-containing salt substitutes unless recommended by your doctor.
- Monitor blood pressure regularly, as the medicine may cause low blood pressure and dizziness.
- Stand up slowly from sitting or lying down to reduce the risk of dizziness or fainting.
- Consult your doctor if you experience muscle weakness, an irregular heartbeat, or persistent vomiting.
- Avoid drinking alcohol with this medicine as it can increase the risk of side effects.
- If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using this medicine.
Drug Interactions
- Medicines such as enalapril and ramipril may increase potassium levels and the risk of hyperkalaemia.
- Medicines such as losartan and telmisartan may increase potassium levels when taken with spironolactone.
- Amiloride and eplerenone may increase the risk of dangerously high potassium levels.
- Painkillers such as ibuprofen and diclofenac may reduce the diuretic effect and increase the risk of kidney problems.
- Spironolactone may increase lithium levels and the risk of toxicity.
- Spironolactone may affect digoxin levels and interfere with certain laboratory tests used to monitor it.
Note: Inform your doctor about all medicines and supplements you take before starting Silectone 25 Tablet. Regular monitoring of potassium levels and kidney function may be necessary.
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
